Ortho RTI Submits Application for Rotator Cuff Repair

Ortho Regenerative Technologies (Ortho RTI) has submitted an Investigational New Drug application to FDA for the initiation of a Phase I/II clinical trial of ORTHO-R in rotator cuff tear repair. Enrollment is expected to start in 2Q21.

The prospective, randomized, controlled and blinded U.S. study will examine ORTHO-R combined with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us